Citations

Showing 10 of 108094 citations.

Robotic‐assisted bronchoscopy versus CT‐guided transthoracic biopsy for diagnosis of pulmonary nodules
Lee‐Mateus, Alejandra Yu , Reisenauer, Janani , Garcia‐Saucedo, Juan C. , Abia‐Trujillo, David , Buckarma, EeeLN H. , Edell, Eric S. , Grage, Rolf A. , Bowman, Andrew W. , Labarca, Gonzalo , Johnson, Margaret M. , Patel, Neal M. , Fernández-Bussy, Sebastián , Yu Lee-Mateus, Alejandra , Bowman, Andrew W , Labarca, Gonzalo , Reisenauer, Janani S , Buckarma, EeeLN , Johnson, Margaret M , Abia-Trujillo, David

Mayo Clinic

Respirology | September 15, 2022 | Volume: 28 | Issue: 1 | Pages: 66-73

10.1111/resp.14368 | PMID 36104312 Get It

AbstractBackground and ObjectiveCurrently, computed tomography‐guided transthoracic biopsy (CTTB) is the most accurate diagnostic approach for pulmonary nodules suspected of malignancy. Traditional bronchoscopy has shown suboptimal diagnostic sensitivity, but the emergence of robotic‐assisted bronchoscopy (RAB) has the potential to improve diagnostic accuracy, maximize diagnostic yield and complete mediastinal and hilar staging in a single procedure. We aim to assess the efficacy and diagnostic performance of RAB compared to CTTB for diagnosing pulmonary nodules suspected of lung cancer.MethodsA multicenter retrospective review of consecutive patients who underwent RAB and CTTB for evaluating pulmonary nodules from January 2019 to March 2021 at Mayo Clinic Florida and Mayo Clinic Rochester, United States. Clinical and demographic information, nodule characteristics, outcomes and complications were compared between RAB and CTTB.ResultsA total of 225 patients were included: 113 in the RAB group and 112 in the CTTB group. Overall diagnostic yield was 87.6% for RAB and 88.4% for CTTB. For malignant disease, RAB had a sensitivity of 82.1% and a specificity of 100%, CTTB had a sensitivity of 88.5% and a specificity of 100%. Complication rate was significantly higher for CTTB compared to RAB (17% vs. 4.4%; p = 0.002).ConclusionRAB, when available, can be as accurate as CTTB for sampling pulmonary nodules with similar or reduced complications and should be considered as a means for nodule biopsy, particularly when mediastinal staging is also clinically warranted.
Influence of the area of the aqueduct and region of interest on quantification of stroke volume in healthy volunteers using phase-contrast cine magnetic resonance imaging
Zhang, Hongri , Yang, Haixin, Duan, Weike , Elder, Benjamin D. , Duan, Weike, Li, Xiaopan , Wang, Yixin, Cogswell, Petrice M.

Mayo Clinic

Acta Radiologica | September 15, 2022 | Volume: 64 | Issue: 4 | Pages: 1615-1622

10.1177/02841851221125916 | PMID 37023028 Get It

Background Phase-contrast cine magnetic resonance imaging (PC-MRI) has been used to measure cerebrospinal fluid (CSF) flow dynamics, but the influence of the area of the aqueduct and region of interest (ROI) on quantification of stroke volume (SV) has not been assessed. Purpose To assess the influence of the area of the ROI in quantifying the aqueductal SV measured with PC-MRI within the cerebral aqueduct. Material and Methods Nine healthy volunteers (mean age = 29.6 years) were enrolled in the study, and brain MRI examinations were performed on a 3.0-T system. Quantitative analysis of the aqueductal CSF flow was performed using manual ROI placement. ROIs were separately drawn for each of the 12 phases of the cardiac cycle, and changes in aqueduct size during the cardiac cycle were determined. The SV was calculated using 12 different aqueductal ROIs and compared with the SV calculated using a fixed ROI size. Results There was variation in the size of the aqueduct during the cardiac cycle. In addition, the measured SV increased with a greater area of the ROI. A significant difference in the calculated SVs with the 12 variable ROIs was observed compared with that using a fixed ROI throughout the cardiac cycle. Conclusion To establish reliable reference values for the SV in future studies, a variable ROI should be considered.
Histological assessment of new cholangioscopy-guided forceps in ERCP biliary stricture sampling: a blinded comparative study
Chen, Zongming Eric, Abusaleh, Rami R., Martin, John A. , Law, Ryan , Levy, Michael J. , Petersen, Bret T. , Law, Ryan J, Petersen, Bret, Vargas, Eric J. , Wang, Yaohong , Abusaleh, Rami , Storm, Andrew C. , Dayyeh, Barham K. Abu , Levy, Michael J. , Petersen, Bret T. , Chandrasekhara, Vinay

Mayo Clinic

Endoscopy International Open | September 14, 2022 | Volume: 10 | Issue: 09 | Pages: E1233-E1237

10.1055/a-1897-4686 | PMID 36118635 Get It

Abstract Background and study aims Obtaining quality tissue during ERCP biliary stricture sampling is of paramount importance for a timely diagnosis. While single-operator cholangioscopy (SOC)-guided biopsies have been suggested to be the superior biliary tissue acquisition modality given direct tissue visualization, less is known about the specimen histological quality. We aimed to analyze the specimen quality of SOC biopsies and compare the new generation forceps with prior “legacy” forceps. Patients and methods Patients who underwent SOC from January 2017-August 2021 for biliary sampling were reviewed. In February 2020, the SOC-guided biopsy forceps were changed from legacy SpyBite to the SpyBite Max forceps (max). Specimens were assessed by blinded pathologists for crush artifact (none, mild, or severe) and gross size (greatest dimension in mm). Crush artifact and gross size were compared between the two groups. The diagnostic performance characteristics for cholangiocarcinoma (CCA), were assessed in an exploratory fashion. Results Eighty-one patients (max = 27, legacy = 54) with similar baseline characteristics were included in this study. On blinded pathological assessment, 58 % had crush artifact, without significant differences between the two groups (Max 63 % vs. Legacy 56 %; P = 0.64). A similar mean specimen size was found (max 3 mm vs. legacy 3.2 mm; P = 0.24). The overall prevalence of CCA was 40 %. The sensitivity, specificity, positive predictive value, and negative predictive value of the entire cohort using a combination of cytology, fluorescence in situ hybridization, and SOC-guided biopsies were 78.1 %, 91.8 %, 86.2 %, and 86.5 %, respectively. No difference between legacy or max groups was found. Conclusions A high rate of crush artifact was found in SOC-guided biopsy specimens. Further investigation regarding proper biopsy technique and handling is necessary to increase the diagnostic yield with SOC-guided biopsies.
Optimization of Patient Positioning for the Sonographic Evaluation of Gallstone Impaction: Analysis of Gallbladder Orientation Based on Computed Tomography
Calhoun, Brendan, Arora, Jyoti , Middleton, William D. , Zulfiqar, Maria , Calhoun, Brendan R., Shetty, Anup S.

Mayo Clinic

Ultrasound Quarterly | September 14, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/ruq.0000000000000620 | PMID 36103429 Get It

Abstract An important sonographic sign of cholecystitis is stone impaction in the gallbladder neck. Demonstration of stone mobility excludes impaction. The purpose of this study is to analyze the orientation of the gallbladder on computed tomography and determine the patient position most likely to facilitate stone mobility. ImageJ processing software was used to determine the x (transverse), y (anterior-posterior), and z (craniocaudal) coordinates for the gallbladder neck and fundus in 544 consecutive computed tomography examinations. The differences in the fundal and neck coordinates were used to determine the likelihood of moving a stone from the neck to the fundus for the left and right lateral decubitus positions (x coordinates), the prone position (y coordinates), and the upright position (z coordinates). The coordinate with the largest difference was considered to predict the position most likely to facilitate stone motion. The difference in position of the fundus and neck was greatest in the y-, z-, and x-axis in 232 (42.6%), 194 (35.7%), and 118 (21.7%) of patients, respectively. For body mass index (BMI) less than 25 kg/m2, the difference was greatest in the z-axis (59.8%). For BMI greater than 25 kg/m2, the difference was greatest in the y-axis (47.1%). Based on their relative location, the optimal position to facilitate gallstone mobility from the gallbladder neck to fundus was most often prone (especially in high BMI patients), followed by upright (especially in low BMI patients), followed by right lateral decubitus. The left lateral decubitus position was never optimal.
Poly(ADP-ribose) promotes toxicity of C9ORF72 arginine-rich dipeptide repeat proteins
Gao, Junli , Mewborne, Quinlan T. , Girdhar, Amandeep , Sheth, Udit , Coyne, Alyssa N. , Punathil, Ritika , Kang, Bong Gu , Dasovich, Morgan , Veire, Austin M. , Hernandez, Mariely DeJesus, Liu, Shuaichen , Shi, Zheng , Dafinca, Ruxandra , Talbot, Kevin , Zhang, Yong‐Jie , Petrucelli, Leonard , Blitterswijk, Marka van , Guo, Lin , Dawson, Ted M. , Veire, Austin , DeJesus Hernandez, Mariely, Fouquerel, Elise , Talbot, Kevin , Kam, Tae-In , Zhang, Yong-Jie , Dickson, Dennis W , Petrucelli, Leonard , van Blitterswijk, Marka , Guo, Lin , Dawson, Ted M , Dawson, Valina L , Leung, Anthony K L , Lloyd, Thomas E , Gendron, Tania F , Rothstein, Jeffrey D , Zhang, Ke , Coyne, Alyssa N , Sheth, Udit , Liu, Shuaichen, Kam, Tae‐In , Dickson, Dennis W. , Dawson, Valina L. , Gendron, Tania F. , Rothstein, Jeffrey D. , Zhang, Ke

Mayo Clinic

Science Translational Medicine | September 14, 2022 | Volume: 14 | Issue: 662 | Pages: No page available

10.1126/scitranslmed.abq3215 | PMID 36103513 Get It

Arginine-rich dipeptide repeat proteins (R-DPRs), abnormal translational products of a GGGGCC hexanucleotide repeat expansion in C9ORF72 , play a critical role in C9ORF72 -related amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), the most common genetic form of the disorders (c9ALS/FTD). R-DPRs form liquid condensates in vitro, induce stress granule formation in cultured cells, aggregate, and sometimes coaggregate with TDP-43 in postmortem tissue from patients with c9ALS/FTD. However, how these processes are regulated is unclear. Here, we show that loss of poly(ADP-ribose) (PAR) suppresses neurodegeneration in c9ALS/FTD fly models and neurons differentiated from patient-derived induced pluripotent stem cells. Mechanistically, PAR induces R-DPR condensation and promotes R-DPR–induced stress granule formation and TDP-43 aggregation. Moreover, PAR associates with insoluble R-DPR and TDP-43 in postmortem tissue from patients. These findings identified PAR as a promoter of R-DPR toxicity and thus a potential target for treating c9ALS/FTD.
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
Hajnik, Renee L. , Plante, Jessica A. , Liang, Yuejin , Alameh, Mohamad‐Gabriel , Tang, Jinyi , Bonam, Srinivasa Reddy , Zhong, Chaojie, Adam, Awadalkareem, Scharton, Dionna , Rafael, Grace, Liu, Yang , Hazell, Nicholas C., Sun, Jiaren , Shi, Pei‐Yong , Wang, Tian , Walker, David H. , Plante, Kenneth S. , Soong, Lynn , Shi, Pei-Yong , Wang, Tian , Sun, Jie , Weissman, Drew , Weaver, Scott C , Plante, Kenneth S , Hu, Haitao , Tang, J , Liu, Yang , Sun, Jie

Mayo Clinic

Science Translational Medicine | September 14, 2022 | Volume: 14 | Issue: 662 | Pages: No page available

10.1126/scitranslmed.abq1945 | PMID 36103514 Get It

Emergence of SARS-CoV-2 variants of concern (VOCs), including the highly transmissible Omicron and Delta strains, has posed constant challenges to the current COVID-19 vaccines that principally target the viral spike protein (S). Here, we report a nucleoside-modified messenger RNA (mRNA) vaccine that expresses the more conserved viral nucleoprotein (mRNA-N) and show that mRNA-N vaccination alone can induce modest control of SARS-CoV-2. Critically, combining mRNA-N with the clinically proven S-expressing mRNA vaccine (mRNA-S+N) induced robust protection against both Delta and Omicron variants. In the hamster models of SARS-CoV-2 VOC challenge, we demonstrated that, compared to mRNA-S alone, combination mRNA-S+N vaccination not only induced more robust control of the Delta and Omicron variants in the lungs but also provided enhanced protection in the upper respiratory tract. In vivo CD8 + T cell depletion suggested a potential role for CD8 + T cells in protection conferred by mRNA-S+N vaccination. Antigen-specific immune analyses indicated that N-specific immunity, as well as augmented S-specific immunity, was associated with enhanced protection elicited by the combination mRNA vaccination. Our findings suggest that combined mRNA-S+N vaccination is an effective approach for promoting broad protection against SARS-CoV-2 variants.
A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections
Blaskovich, Mark A. T. , Hansford, Karl A. , Butler, Mark S. , Ramu, Soumya , Kavanagh, Angela M. , Prasetyoputri, Anggia , Pitt, Miranda E. , Huang, Johnny X. , Lindahl, Fredrik, Ziora, Zyta M. , Bradford, Tanya A. , Muldoon, Craig, Premraj, Rajaratnam , Pelingon, Ruby , Edwards, David J. , Amado, Maite , Woischnig, Anne-Kathrin , Breidenstein, Elena B. M. , Stincone, Anna, Karau, Melissa J. , Greenwood‐Quaintance, Kerryl E. , Wootton, Mandy , James, Meagan L. , Hutton, M. , Mahdi, Layla K. , Trott, Darren J. , Wu, Xiaoqian, Niles, Samantha , Lewis, Kim , Yim, Juwon , Rice, Seth, Rybak, Michael J. , Ishmael, Chad R. , Hori, Kellyn R. , Francis, Kevin P. , Jarrad, Angie M , Prasetyoputri, Anggia , Pitt, Miranda E , Huang, Johnny X , Ziora, Zyta M , Bradford, Tanya , Rajaratnam, Premraj , Pelingon, Ruby , Zhang, Bing , Elliott, Alysha G , Zuegg, Johannes , Coin, Lachlan , Khanna, Nina , Stincone, Anna , Mason, Clive , Cho, Hye-Kyung , Karau, Melissa , Greenwood-Quaintance, Kerryl , Patel, Robin , Wootton, Mandy , James, Meagan L , Hutton, Melanie L , Lyras, Dena , Ogunniyi, Abiodun D , Mahdi, Layla K , Niles, Samantha , Lewis, Kim , Smith, Jordan R , Barber, Katie E , Rybak, Michael J , Ishmael, Chad R , Hori, Kellyn R , Bernthal, Nicholas M , Francis, Kevin P , Paterson, David L. , Cooper, Matthew A , Blaskovich, Mark A T , Edwards, David J., Khan, Nawaz, Patel, Robin , Roberts, Jason A

Mayo Clinic

Science Translational Medicine | September 14, 2022 | Volume: 14 | Issue: 662 | Pages: No page available

10.1126/scitranslmed.abj2381 | PMID 36103517 Get It

Drug-resistant Gram-positive bacterial infections are still a substantial burden on the public health system, with two bacteria ( Staphylococcus aureus and Streptococcus pneumoniae ) accounting for over 1.5 million drug-resistant infections in the United States alone in 2017. In 2019, 250,000 deaths were attributed to these pathogens globally. We have developed a preclinical glycopeptide antibiotic, MCC5145, that has excellent potency (MIC 90 ≤ 0.06 μg/ml) against hundreds of isolates of methicillin-resistant S. aureus (MRSA) and other Gram-positive bacteria, with a greater than 1000-fold margin over mammalian cell cytotoxicity values. The antibiotic has therapeutic in vivo efficacy when dosed subcutaneously in multiple murine models of established bacterial infections, including thigh infection with MRSA and blood septicemia with S. pneumoniae , as well as when dosed orally in an antibiotic-induced Clostridioides difficile infection model. MCC5145 exhibited reduced nephrotoxicity at microbiologically active doses in mice compared to vancomycin. MCC5145 also showed improved activity against biofilms compared to vancomycin, both in vitro and in vivo, and a low propensity to select for drug resistance. Characterization of drug action using a transposon library bioinformatic platform showed a mechanistic distinction from other glycopeptide antibiotics.
Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma
Franses, Joseph W. , Burgoyne, Adam M. , Mody, Kabir , Lennerz, Jochen K. , Chang, Jeremy , Imperial, Robin John Lester , Dybel, Stacey N., Dinh, Thi M, Weipert, Caroline , Hsiehchen, David , Imperial, Robin, Lennerz, Jochen , Lim, Mir , Masannat, Jude

Mayo Clinic

The Oncologist | September 14, 2022 | Volume: 27 | Issue: 11 | Pages: e908-e911

10.1093/oncolo/oyac189 | PMID 36103364 Get It

Abstract Advanced hepatocellular carcinoma (HCC) is responsive to immune checkpoint inhibitors, but there are currently no known biomarkers to predict treatment benefit. Blood TMB (bTMB) estimation via circulating tumor DNA (ctDNA) profiling can provide a convenient means to estimate HCC TMB. Here we provide the first landscape of bTMB in advanced HCC using a commercially available next-generation sequencing assay, show that it is approximately three times as high as matched tissue TMB, and show that bTMB correlates with NAFLD cirrhosis etiology and the presence of genomic alterations in HTERT and TP53. These results lay the foundation for subsequent studies evaluating bTMB as an immune therapy predictive biomarker in HCC.
Psychosocial considerations in the combined bariatric surgery and organ transplantation population: a review of the overlapping pathologies and outcomes
Fipps, David C. , Sinha, Shirshendu , Diwan, Tayyab S. , Clark, Matthew M. , Fipps, David C

Mayo Clinic

Current Opinion in Organ Transplantation | September 14, 2022 | Volume: 27 | Issue: 6 | Pages: 514-522

10.1097/mot.0000000000001023 | PMID 36103143 Get It

Purpose of review This review highlights the salient data of the psychosocial concerns that influence outcomes of bariatric surgery and organ transplantation. Recent findings Bariatric surgery has emerged as an important intervention with data supporting substantial and sustained weight loss, enhanced quality of life, remission of obesity-related medical comorbidities, and improved long-term patient and graft survival in transplant patients. Depression, suicide, anxiety, posttraumatic stress disorder, alcohol use, adherence, and psychopharmacology considerations can influence outcomes of both these surgeries. Summary Obesity is increasingly prevalent among patients pursuing transplantation surgery, and it is often a factor in why a patient needs a transplant. However, obesity can be a barrier to receiving a transplant, with many centers implementing BMI criteria for surgery. Furthermore, obesity and obesity-related comorbidities after transplant can cause poor outcomes. In this context, many transplant centers have created programs that incorporate interventions (such as bariatric surgery) that target obesity in transplant candidates. A presurgery psychosocial assessment is an integral (and required) part of the process towards receiving a bariatric surgery and/or a transplantation surgery. When conducting a dual (bariatric and transplantation surgery) psychosocial assessment, it is prudent to understand the overlap and differentiation of specific psychosocial components that influence outcomes in these procedures.
Primary Leptomeningeal Lymphoma: Clinicopathologic Features of 2 Rare Phenotypes
Vizcaíno, M. Adelita , Giannini, Caterina , King, Rebecca L. , Raghunathan, Aditya , Giannini, Caterina , Johnson, Derek R. , Yang, Tong , Raghunathan, Aditya

Mayo Clinic

Journal of Neuropathology & Experimental Neurology | September 14, 2022 | Volume: 81 | Issue: 12 | Pages: 1002-1007

10.1093/jnen/nlac084 | PMID 36102830 Get It

Abstract Primary leptomeningeal lymphoma is exceedingly rare. We describe 2 rare lymphoma cases with exclusive leptomeningeal disease: 1 ALK-positive (ALK+) anaplastic large cell lymphoma (ALCL) and 1 primary effusion lymphoma (PEL). Case 1: A 19-year-old man presented with symptoms concerning for leptomeningitis. Cerebrospinal fluid (CSF) analysis revealed lymphocytic pleocytosis. Spine MRI demonstrated pial enhancement from T10 through the conus medullaris and cauda equina enhancement/thickening. A biopsy showed leptomeningeal involvement by large lymphoma cells with hallmark cells and brisk mitotic activity. By immunohistochemistry, cells were CD7/CD30-positive with cytoplasmic ALK staining. No systemic disease was identified. The diagnosis of primary leptomeningeal ALK+ ALCL was made. Despite 2 CSF relapses requiring systemic therapy and autologous bone marrow transplant, the patient was in complete clinical remission 9 years after the diagnosis. Case 2: A 60-year-old, human immunodeficiency virus-positive man presented with symptoms suggestive of leptomeningitis. Brain MRIs revealed multifocal, supratentorial, and infratentorial leptomeningeal enhancement. A right frontal biopsy demonstrated leptomeningeal involvement by large lymphoma cells negative for B-cell immunostains, but CD138, MUM-1, and HHV8-positive, with aberrant CD3 expression. EBV-encoded RNA in situ hybridization was positive. In absence of solid lesions/extracranial involvement, the diagnosis of leptomeningeal PEL was rendered. Despite initial complete remission after chemotherapy, the patient died 9 months later.